The Belgium health authority has approved Bellerophon Therapeutics‘ plans to initiate a Phase 2 clinical trial for INOpulse, the…
Articles by Patrícia Silva, PhD
Pulmatrix recently reported topline results from a Phase 1 pilot study evaluating PUR0200, an iSPERSE dry powder formulation incorporating…
A team of researchers at the University of North Carolina Wilmington (UNCW) is testing an exercise table that may help patients with…
ProterixBio, which specializes in products that aid in the development of new treatments for pulmonary conditions, including chronic obstructive pulmonary disease…
A new practical guide titled “Managing Malnutrition in COPD” was recently launched by 10 key British professional and…
San Francisco-based biopharma Cytokinetics initiated a Phase 2 clinical trial to evaluate the effect of CK-107 on physical function in patients…
Pulmatrix, a pharmaceutical company focused on developing novel inhaled drugs for lung diseases like chronic obstructive pulmonary disease (COPD),…
Four Lung Institute facilities in Tampa, Scottsdale, Nashville and Pittsburg, treat restrictive and obstructive lung diseases using stem cells from the…
Results from a Novartis Pharmaceuticals Canada study to assess the company’s Ultibro Breezhaler were published in the New England…
Researchers from the University of Texas Medical Branch (UTMB) at Galveston are studying the latest trends for pulmonary rehabilitation…